Learn More
Selleck Chemical LLC Sovleplenib E4580-5MG

Supplier: Selleck Chemical LLC E45805MG
Sovleplenib(HMPL-523) is a highly potent and selective SYK inhibitor with IC50 of 0 025 M that exhibits anti-tumor activities in vitro and in vivo Sovleplenib exhibits synergistic activities in combination with BTK PI3K and Bcl2 family inhibitors in killing human-diffused large B cell lymphoma (DLBCL)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.